title: [Ruxolitinib as a bridge to allogeneic hematopoietic cell transplantation in a patient with idiopathic myelofibrosis].
authors: Servicio de Hematología, Hospital Universitario Vall d'Hebron, Barcelona, España. Electronic address: pebarba@vhebron.net.
authors: Pere
authors: P
authors: Barba
authors: Servicio de Hematología, Hospital Universitario Vall d'Hebron, Barcelona, España.
authors: María Laura
authors: ML
authors: Fox
authors: Servicio de Hematología, Hospital Universitario Vall d'Hebron, Barcelona, España.
authors: Adoración
authors: A
authors: Blanco
authors: Servicio de Hematología, Hospital Universitario Vall d'Hebron, Barcelona, España.
authors: David
authors: D
authors: Valcárcel
mesh_terms: D064591:Allografts; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D009570:Nitriles; D036102:Peripheral Blood Stem Cell Transplantation; D017354:Point Mutation; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000235:genetics / Q000628:therapy; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines; D035781:Siblings; D013163:Splenomegaly / Q000188:drug therapy / Q000209:etiology; D019172:Transplantation Conditioning
chemical_list: D009570:Nitriles; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; C507924:JAK2 protein, human; D053614:Janus Kinase 2